Explore

Trendline Trendline
Decoy Therapeutics CEO to Discuss Early Drug Development at hVIVO Event

Decoy Therapeutics CEO to Discuss Early Drug Development at hVIVO Event

Decoy Therapeutics CEO to Discuss Early Drug Development at hVIVO Event
Trendline Trendline
Vertex Pharmaceuticals Unveils Promising Data on ALYFTREK for Cystic Fibrosis in Young Children

Vertex Pharmaceuticals Unveils Promising Data on ALYFTREK for Cystic Fibrosis in Young Children

Vertex Pharmaceuticals Unveils Promising Data on ALYFTREK for Cystic Fibrosis in Young Children
Trendline Trendline
CicadaBio Presents New Data on CC-18 for Muscle-Preservation Weight Loss at ADA 2026

CicadaBio Presents New Data on CC-18 for Muscle-Preservation Weight Loss at ADA 2026

CicadaBio Presents New Data on CC-18 for Muscle-Preservation Weight Loss at ADA 2026
Trendline Trendline
New Diabetes Drug Retatrutide Shows Dual Benefits in Blood Sugar and Weight Management

New Diabetes Drug Retatrutide Shows Dual Benefits in Blood Sugar and Weight Management

New Diabetes Drug Retatrutide Shows Dual Benefits in Blood Sugar and Weight Management
Trendline Trendline
Mayim Bialik's Adverse Reaction to GLP-1 Medication Highlights Potential Risks

Mayim Bialik's Adverse Reaction to GLP-1 Medication Highlights Potential Risks

Mayim Bialik's Adverse Reaction to GLP-1 Medication Highlights Potential Risks
Trendline Trendline
Chai Discovery and Pfizer Partner to Accelerate Drug Discovery with AI

Chai Discovery and Pfizer Partner to Accelerate Drug Discovery with AI

Chai Discovery and Pfizer Partner to Accelerate Drug Discovery with AI
Trendline Trendline
Amgen Expands U.S. Manufacturing as BioNTech Scales Back Amid Market Shifts

Amgen Expands U.S. Manufacturing as BioNTech Scales Back Amid Market Shifts

Amgen Expands U.S. Manufacturing as BioNTech Scales Back Amid Market Shifts
Trendline Trendline
Owkin and Sanofi Collaborate to Develop AI-Driven Biopharma Agents for Drug Discovery

Owkin and Sanofi Collaborate to Develop AI-Driven Biopharma Agents for Drug Discovery

Owkin and Sanofi Collaborate to Develop AI-Driven Biopharma Agents for Drug Discovery
Trendline Trendline
AstraZeneca CEO Highlights AI's Role in Enhancing Drug Development Success

AstraZeneca CEO Highlights AI's Role in Enhancing Drug Development Success

AstraZeneca CEO Highlights AI's Role in Enhancing Drug Development Success
Trendline Trendline
Bio-Techne and Refeyn Launch Workflow for Bispecific Antibody Characterization

Bio-Techne and Refeyn Launch Workflow for Bispecific Antibody Characterization

Bio-Techne and Refeyn Launch Workflow for Bispecific Antibody Characterization
Trendline Trendline
Bio-Techne and Refeyn Launch Integrated Workflow for Antibody Characterization

Bio-Techne and Refeyn Launch Integrated Workflow for Antibody Characterization

Bio-Techne and Refeyn Launch Integrated Workflow for Antibody Characterization
USA Today USA Today
I lost 80 pounds on a GLP‑1—Hers is making treatment more accessible

I lost 80 pounds on a GLP‑1—Hers is making treatment more accessible

Hers launches a GLP‑1 weight loss membership starting at $39. Here's how the program works, what's included, and who may qualify.